Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy and Improve Functional Outcomes Following Peripheral Nerve Injury and Repair
Abstract
We are currently completing the set-up phase for this study. We have hired and trained all necessary staff. We have finalized drug distribution plans with Theratechnologies and the JHH research pharmacy. We have finalized our data management plan with REDCap and our biostatistician. We have received IRB approval from JHU IRB and IRB waivers from our primary recruitment sites (Union Memorial Hospital and University of Maryland Medical Center/Shock Trauma). The final step with regards to study set up prior to beginning recruitment will be to receive HRPO approval.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2017
- Accession Number
- AD1046170
Entities
People
- Sami Tuffaha
Organizations
- Johns Hopkins University